Market revenue in 2023 | USD 20.4 million |
Market revenue in 2030 | USD 40.7 million |
Growth rate | 10.4% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 57.84% in 2023. Horizon Databook has segmented the Italy deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Italy deep brain stimulation devices market is anticipated to exhibit consistent growth rate of 10.2% over the forecast period due to growing prevalence of neurological diseases and increasing research activities for the development of new deep brain stimulation devices.
For instance, in July 2017, a spinoff company of University of Milan developed and patented a new deep brain stimulation device for the treatment of PD. Moreover, increasing incidence of epilepsy and OCD is a major factor driving this market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account